News Press Releases Genenta’s CEO to present at the U.S. Senate meeting on “Cross-Border Investments and Strategies in the Biotechnology Sector: A Transatlantic Perspective” Oct 23, 2024 Genenta Secures Approval for Innovative Trial for Metastatic Renal Cell Cancer Oct 02, 2024 Genenta Welcomes New Directors John L. Cantello, Lauren H. Chung, Armon R. Sharei, and Todd Wider May 06, 2024 Learn More Upcoming Events More events are coming soon. Learn More Learn More Corporate Information More information is coming soon. Financial Metrics Price Change Day High Day Low Volume Oct 29, 2024 10:33 AM EDT Stock Chart Minimum 15 minutes delayed. Source: Learn More
Genenta’s CEO to present at the U.S. Senate meeting on “Cross-Border Investments and Strategies in the Biotechnology Sector: A Transatlantic Perspective” Oct 23, 2024
Genenta Welcomes New Directors John L. Cantello, Lauren H. Chung, Armon R. Sharei, and Todd Wider May 06, 2024